Trial Profile
The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- 12 Sep 2012 New trial record